Vaccine campaigns were already unrolling unequally, so Johnson & Johnson’s candidate raises some tricky ethical questions for the coming months.
The U.K. announced its variant is more deadly, and new studies suggest these mutants may weaken our vaccines. Hope remains, as science can help us adapt to these ever-changing coronaviruses.
Monoclonal antibody therapies have helped prevent hospitalizations and severe symptoms in high-risk coronavirus patients. But recent viral mutations may render them ineffective.
Gothamist is funded by sponsors and member donations